Vergleich

TRAF6 Peptide - middle region (AAP30226)

ArtNr AAP30226
Hersteller AVIVA Systems Biology
Menge 100 ug
Kategorie
Typ Peptides
Format Lyophilized powder
Applikationen WB
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias MGC:3310, RNF85
Similar products TRAF6
Lieferbar
Description
This is a synthetic peptide designed for use in combination with anti-TRAF6 antibody (Catalog #: ARP30226_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Gene symbol
TRAF6
Protein size
522
Molecular weight
59kDa
Product format
Lyophilized powder
Gene id
7189
Reconstitution and storage
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.
Partner proteins
IRAK1, IRAK2, IRAK3, IRF7, MALT1, MAP3K14, TAB3, TICAM1, TICAM1, TICAM2, TRAF6, UBB, UBB, ZFAND5, ABL1, ATP6V1E1, CAV1, CBL, CD40, CYLD, ECSIT, EDA2R, FHL2, HSPA4, IL17RB, IRAK1, IRAK2, IRAK3, IRAK4, IRF5, IRF7, IRF8, KCNQ1, MALT1, MAP2K1, MAP2K6, MAP2K7, MAP3K14, MAP3K3, MAP3K5, MAP3K7, MAP3K8, MAPK14, MAPK8, MAST2, MAVS, MBP, NGFR, NGFRAP1, OTUD7B, PELI3, PRKCZ, PSMB5, PSMC1, PSMC2, PSMC3, PSMD1, PSMD12, PSMD13, PSMD6, PSMD7, PTPN6, RIPK2, SIGIRR, SPHK1, SQSTM1, SRC, STRADB, SYK, TAB1, TAB2, TAB3, TAX1BP1, TDP2, TICAM1, TICAM2, TIFA, TIRAP, TLR3, TMEM189-UBE2V1, TNFAIP3, TNFRSF11A, TNFRSF13B, TNFRSF19, TNFSF11, TRAF2, TRAF3IP2, TRAF4, TRAF6, TRAF7, TRAFD1, TRAM1, TRIM37, UBB, UBE2N, USP7, XIAP, ZFAND5, ZMYND11, ZNF675, ZRANB1, ASXL2, BMPR1B, CD40, CTPS, DDX3X, EDA2R, EIF4E2, EPPK1, Ecsit, FHL2, GANAB, HSPB2, IARS, IKBKG, IL17RA, IRAK1, IRAK2, IRAK3, IRAK4, KCNQ1, MAP3K14, MAP3K5, MAP3K7, MAST2, MCM7, MTHFD1, MYD88, Map3k7, NASP, NGFR, NTRK1, NTRK2, OTUD7B, PAICS, PELI3, PFAS, PPP4C, PRKCZ, PSEN1, PSMB5, PSMC1, PSMC2, PSMC3, PSMD1, PSMD12, PSMD13, PSMD3, PSMD7, RIPK2, RUNX1, SDCBP, SIGIRR, SPOP, SQSTM1, SRC, STRADB, SYK, TAB1, TAB2, TAB3, TARS, TAX1BP1, TDP2, TGFBR1, TIFA, TIRAP, TJP2, TNFAIP3, TNFRSF11A, TNFRSF13B, TRAF2, TRAF3IP1, TRAF6, TRIM37, UBC, UBE2N, UBE2V1, USP7, VARS, VCP, VDAC1, XIAP, ZFAND5, ZMYND11, ZNF675, ZRANB1
Description of target
TRAF6 is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from members of the TNF receptor superfamily. This protein mediates the signaling not only from the members of the TNF receptor superfamily, but also from the members of the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein.The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from members of the TNF receptor superfamily. This protein mediates the signaling not only from the members of the TNF receptor superfamily, but also from the members of the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. Two alternatively spliced transcript variants encoding identical proteins have been reported.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 100 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen